Corvaton Retard

Corvaton Retard contains molsidomine, a medication used to improve blood flow and manage certain cardiovascular conditions. It is designed for oral use and is manufactured by Cheplapharm Arzneimittel Gmbh.

Corvaton Retard is primarily used to enhance blood circulation and support cardiovascular health. It may be prescribed for conditions related to poor blood flow, such as angina or peripheral vascular disease. The medication works by relaxing blood vessels, which can help to reduce symptoms associated with these conditions.

Common effects of Corvaton Retard may include headaches, dizziness, or flushing. Some users might experience a drop in blood pressure, which can cause lightheadedness. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare professional.

Corvaton Retard should be handled with care, especially by individuals with a history of low blood pressure or severe liver disease. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Always store the medication in a cool, dry place away from direct sunlight.

Corvaton Retard may interact with other medications, particularly those that lower blood pressure or affect blood flow. It is advisable to avoid alcohol while taking this medication, as it can enhance the risk of side effects. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.